Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–5 of 5 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Von Willebrand's Disorder Clear all

Completed Phase 1 Interventional

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

NCT04770935

View directory record Official record

Conditions: Von Willebrand's Disease (VWD)
Interventions: efanesoctocog alfa (BIVV001); Drug
Lead sponsor: Bioverativ, a Sanofi company; Industry
Eligibility: 18 Years to 65 Years

Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Iowa City, Iowa • Pittsburgh, Pennsylvania

Source: ClinicalTrials.gov public record

Updated Sep 24, 2025 · Synced May 22, 2026, 1:13 AM EDT

Completed Phase 4 Interventional

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

NCT00168090

View directory record Official record

Conditions: Von Willebrand Disease, Blood Coagulation Disorders, Blood Platelet Disorders, Hematologic Disease
Interventions: Blood coagulation Factor VIII and vWF, human; Drug
Lead sponsor: CSL Behring; Industry
Eligibility: Not listed

Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Source: ClinicalTrials.gov public record

Updated Feb 10, 2011 · Synced May 22, 2026, 1:13 AM EDT

Recruiting No phase listed Observational

The Severe Von Willebrand Disease (sVWD) Patient Registry

NCT05437536

View directory record Official record

Conditions: VWD - Von Willebrand's Disease
Interventions: Not listed
Lead sponsor: VWD Connect Foundation; Other
Eligibility: Not listed

Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2031
U.S. locations: 1
States / cities: Wellington, Florida

Source: ClinicalTrials.gov public record

Updated Apr 21, 2026 · Synced May 22, 2026, 1:13 AM EDT

Completed Not applicable Interventional

Treatment and Management of Women With Bleeding Disorders

NCT00111215

View directory record Official record

Conditions: Menorrhagia, Blood Coagulation Disorders, Blood Platelet Disorders, Von Willebrand Disease, Hematologic Disease
Interventions: Tranexamic Acid, Desmopressin Acetate; Drug
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 50 Years · Female only

Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 6
States / cities: Atlanta, Georgia • East Lansing, Michigan • Rochester, Minnesota + 3 more

Source: ClinicalTrials.gov public record

Updated Mar 12, 2007 · Synced May 22, 2026, 1:13 AM EDT

Withdrawn No phase listed Observational Accepts healthy volunteers

Changes in Bleeding and Clotting During the Menstrual Cycle

NCT00480545

View directory record Official record

Conditions: Von Willebrand's Disorder, Healthy
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years · Female only

Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Source: ClinicalTrials.gov public record

Updated Dec 4, 2014 · Synced May 22, 2026, 1:13 AM EDT